Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 25
  • 1
  • 2
  • »
An overview of the modern health care workforce reveals a concerning disparity in the amount of African American medical professionals.
ACCCBuzz spoke with Erika Siegrist at Luminis Health Research Institute to learn more about how technology has helped expand patient access to cancer clinical trials.
At the 2023 National Minority Quality Forum Summit on Health Disparities and Spring Health Braintrust, panelists discussed strategies that can be implemented to improve diversity in clinical trials.
November 13 to 19 is dedicated to National Nurse Practitioner Week, and the Association of Community Cancer Centers (ACCC) is taking this opportunity to recognize its nurse practitioner (NP) members—highlighting the work NPs do to improve access to care, the patient and clinician experience, and patient outcomes.
The ACCC 39th National Oncology Conference opened with two pre-conferences, covering financial advocacy in oncology and the future of cancer care. Learn what care delivery may look like in 2040 and how ACCC is supporting cancer programs and practices through its Financial Advocacy Network.
June 16 to 22 is National Black Family Cancer Awareness Week—a week dedicated to increase awareness of the importance of clinical trial participation and specimen donations for cancer research among Black Americans. Learn what ACCC is doing to address health disparities for all underserved populations across America.
ACCC has partnered with several of its oncology state societies to establish the Appalachian Community Cancer Alliance—a key effort to address disparities in cancer screening and care delivery in the region.
The second post in a three-blog series, ACCCBuzz shares how Carolina Blood and Cancer Care Associates' NOLA initiative is addressing access to care, clinical trials, biomarker testing, and more.
Carolina Blood and Cancer Care Associate's No One Left Alone (or NOLA) initiative is a multi-phase pilot program aimed at lessening disparities in cancer care in three key areas: care access, biomarker testing, and clinical trials.
In 2021, ACCC launched the ACCC Community Oncology Research Institute (ACORI), which builds on ACCC’s mission to achieve equitable cancer care for all patients by forming key community partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event held September 13-14, 2021, to garner participant feedback and guide the future of the institute.
Beginning January 2022, CMS will be required to cover for Medicaid patients the routine costs associated with participating in clinical trials. Learn what states and provider organizations can do to leverage this mandate to address barriers to care in the community and reduce inequities in clinical trial participation.
Older adults with cancer are consistently precluded from participating in clinical trials for promising new treatments. A multi-pronged approach is required to ensure trials are developed for all patients, including paying specific attention to inclusion/exclusion criteria and creating clinically meaningful endpoints that can enhance enrollment efforts in underserved populations.
Poor access to care among AYA patients is not only evident in low clinical trial enrollment. The struggle to access much-needed care continues when treatment concludes. Most AYA cancer survivors must learn to navigate follow-up medical care on their own.
The Road to Recovery Report makes specific recommendations for maintaining the adaptations made necessary to accommodate the disruptions caused by the pandemic. Where possible, the report recommends building on that momentum to spur much-needed change in cancer care and research.
Montana is one of the most rural states in the U.S., with nearly half of its population living in rural regions. Accordingly, accessing healthcare services can be difficult for Montana’s citizens, and gaining access to clinical trials is particularly challenging.
ACCCBuzz sat down with ASCO's Dr. Richard L. Schilsky to look back on his career and look forward to the future breakthroughs in this era and beyond.
Carla Strom, MLA, speaks with ACCCBuzz about her role as an advocate, how this role has evolved, and why listening to the community's voice early and often in clinical trial development and cancer research is vital.
Learn how the PECaD program at Siteman Cancer Center is decreasing disparities in care by monitoring data, engaging the community, supporting research, and ensuring diverse representation in research.
In the final installment of ACCC’s webinar series honoring American Pharmacists Month, experts discussed the integral role pharmacists play in supporting clinical trial research in the community setting, and they identified opportunities for extending the pharmacist role in an increasingly complex research landscape.
At the risk of repeating a phrase that has been exhausted this year, the dawn of 2020 brought with it unprecedented times. Whereas a pandemic on its own would have dominated everything else, this year also brought on an economic depression; a racial awakening; record-breaking wildfires, hurricanes, and floods; political turmoil on an extraordinary scale; and a host of additional unique phenomena. …
    Displaying results 1 - 20 of 25
  • 1
  • 2
  • »